Detalles de la búsqueda
1.
Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.
Cancer Res
; 60(7): 2007-17, 2000 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-10766192
2.
Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
Cancer Res
; 52(11): 3182-8, 1992 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-1375536
3.
Up-regulation of insulin/insulin-like growth factor-I hybrid receptors during differentiation of HT29-D4 human colonic carcinoma cells.
Endocrinology
; 138(5): 2021-32, 1997 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-9112401
4.
Expression of type I, but not type II insulin-like growth factor receptor on both undifferentiated and differentiated HT29 human colon carcinoma cell line.
J Clin Endocrinol Metab
; 75(2): 609-16, 1992 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-1322432
5.
Differential secretory polarity of IGFBP-6 vs. IGFBP-2 and IGFBP-4 in human intestinal epithelial cells: is it a way of modulating IGF-II bioavailability towards the IGF-responsive basolateral surface?
Prog Growth Factor Res
; 6(2-4): 197-206, 1995.
Artículo
en Inglés
| MEDLINE | ID: mdl-8817662
6.
Surface-bound plasmin induces selective proteolysis of insulin-like-growth-factor (IGF)-binding protein-4 (IGFBP-4) and promotes autocrine IGF-II bio-availability in human colon-carcinoma cells.
Int J Cancer
; 72(5): 835-43, 1997 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-9311602
7.
In vivo delayed rejection of tumors and inhibition of delayed-type hypersensitivity by HT-29 human colonic adenocarcinoma cell line.
Cancer Immunol Immunother
; 24(3): 225-30, 1987.
Artículo
en Inglés
| MEDLINE | ID: mdl-3594485
Resultados
1 -
7
de 7
1
Próxima >
>>